{"id":1426,"date":"2025-11-17T04:48:30","date_gmt":"2025-11-17T04:48:30","guid":{"rendered":"https:\/\/www.apifdf.com\/blog\/?p=1426"},"modified":"2025-12-29T13:27:47","modified_gmt":"2025-12-29T13:27:47","slug":"paracetamol-imports-pharma-supply-chain","status":"publish","type":"post","link":"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/","title":{"rendered":"Paracetamol Imports from India: 11 Critical Market Insights"},"content":{"rendered":"<p><span style=\"font-size: 24px; font-weight: 600;\">Market Overview \u2014 Why India Imports Paracetamol<\/span><\/p>\n<section id=\"market-overview\">Although India is a major global producer of Paracetamol API, imports remain strategically important for several reasons: specific high-purity grades or micronized powders not manufactured domestically at scale; contractual global sourcing commitments by multinational formulators operating in India; short-term buffer supply during domestic production hiccups; and procurement of research-grade or injectable-grade acetaminophen from specialized global suppliers.<\/p>\n<p class=\"note\"><strong>Key counts (data through Oct 2025):<\/strong> <strong>214<\/strong> unique exporters supplied acetaminophen to India and <strong>249<\/strong> unique Indian importers were active in import records.<\/p>\n<p>Imports form part of a wider sourcing strategy \u2014 balancing domestic production, imported specialty grades, and cost optimization for finished-dosage exports. This helps Indian formulators maintain uninterrupted supply for hospitals, retail OTC markets, and export consignments.<\/p>\n<\/section>\n<section id=\"ten-year-trends\">\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_81 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Import_Trends_2020%E2%80%932025_up_to_Oct_2025\" >Import Trends (2020\u20132025 up to Oct 2025)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Trend_summary\" >Trend summary<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Top_Exporting_Companies_Suppliers_Leading_Indian_Importers\" >Top Exporting Companies (Suppliers) &amp; Leading Indian Importers<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Top_global_suppliers_to_India_recorded_exporters\" >Top global suppliers to India (recorded exporters)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Leading_Indian_importers_top_buyers_formulators\" >Leading Indian importers (top buyers &amp; formulators)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Destination_Source_Country_Notes_High-Interest_Regions\" >Destination \/ Source Country Notes &amp; High-Interest Regions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Top_regions_markets_searching_or_showing_rising_interest\" >Top regions \/ markets searching or showing rising interest<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Pharmacological_Use_Industrial_Applications\" >Pharmacological Use &amp; Industrial Applications<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Industry_Insights_%E2%80%94_Price_Drivers_Correlations_Procurement_Signals\" >Industry Insights \u2014 Price Drivers, Correlations &amp; Procurement Signals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Future_Trade_Outlook_Strategic_Recommendations_2026%E2%80%932028\" >Future Trade Outlook &amp; Strategic Recommendations (2026\u20132028)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Outlook\" >Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Strategic_recommendations_for_importers_policymakers\" >Strategic recommendations for importers &amp; policymakers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Conclusion_%E2%80%94_Imports_as_a_Strategic_Supply_Lever\" >Conclusion \u2014 Imports as a Strategic Supply Lever<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/#Advance_Your_Pharma_Sourcing_Strategy_with_Clear_Import_Insights\" >Advance Your Pharma Sourcing Strategy with Clear Import Insights<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Import_Trends_2020%E2%80%932025_up_to_Oct_2025\"><\/span>Import Trends (2020\u20132025 up to Oct 2025)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below shows annual import value, volume (kg), and average price per kg. Values are consolidated from verified shipment records through October 2025.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/www.apifdf.com\/blog\/wp-content\/uploads\/2025\/11\/Paracetamol_Import_Trends_2020\u20132025_Till_October_2025-11-14T12-12-28-682Z.png\" alt=\"Paracetamol Imports Analytics\" \/><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Trend_summary\"><\/span>Trend summary<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Price volatility peaked in <strong>2021\u20132022<\/strong> \u2014 a period marked by global raw-material shortages and supply-chain pressure that elevated per-kg prices. Imports dropped in 2023 as domestic production recovered, before rebounding in 2025 (through October) as formulators diversified procurement to manage cost and ensure grade availability. Overall, import volumes in 2025 indicate renewed demand for certain grades and stabilisation of pricing around the low-to-mid USD 4s per kg for many bulk categories.<\/p>\n<\/section>\n<section id=\"suppliers-and-buyers\">\n<h2><span class=\"ez-toc-section\" id=\"Top_Exporting_Companies_Suppliers_Leading_Indian_Importers\"><\/span>Top Exporting Companies (Suppliers) &amp; Leading Indian Importers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Top_global_suppliers_to_India_recorded_exporters\"><\/span>Top global suppliers to India (recorded exporters)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table aria-label=\"Top exporting companies\">\n<thead>\n<tr>\n<th>Exporting Company<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>ANQIU LUAN PHARMACEUTICAL CO LTD<\/td>\n<\/tr>\n<tr>\n<td>MALLINCKRODT CHEMICAL LTD<\/td>\n<\/tr>\n<tr>\n<td>SIGMA ALDRICH CO LLC<\/td>\n<\/tr>\n<tr>\n<td>NOVACYL ASIA PACIFIC LTD<\/td>\n<\/tr>\n<tr>\n<td>ANQIU LUAN PHARMACEUTICAL CO<\/td>\n<\/tr>\n<tr>\n<td>FLAVINE NORTH AMERICA INC<\/td>\n<\/tr>\n<tr>\n<td>HEBEI JIHENG PHARMACEUTICAL CO LTD<\/td>\n<\/tr>\n<tr>\n<td>HEBEI JIHENG GROUP PHARMACEUTICALS CO LTD<\/td>\n<\/tr>\n<tr>\n<td>HEBEI JIHENG GROUP PHARMACEUTICALS<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Leading_Indian_importers_top_buyers_formulators\"><\/span>Leading Indian importers (top buyers &amp; formulators)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table aria-label=\"Top importing companies\">\n<thead>\n<tr>\n<th>Importing Company<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>SIGMA ALDRICH CHEMICALS PVT LTD<\/td>\n<\/tr>\n<tr>\n<td>CHROMACHEMIE LABORATORY PVT LTD<\/td>\n<\/tr>\n<tr>\n<td>LGC PROMOCHEM INDIA PVT LTD<\/td>\n<\/tr>\n<tr>\n<td>SANOFI INDIA LTD<\/td>\n<\/tr>\n<tr>\n<td>SRI KRISHNA PHARMACEUTICALS LTD<\/td>\n<\/tr>\n<tr>\n<td>GRANULES INDIA LTD<\/td>\n<\/tr>\n<tr>\n<td>ADCOCK INGRAM LTD<\/td>\n<\/tr>\n<tr>\n<td>MEDOPHARM<\/td>\n<\/tr>\n<tr>\n<td>SHALINA LABORATORIES PVT LTD<\/td>\n<\/tr>\n<tr>\n<td>MARKSANS PHARMA LTD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"small\">These importers procure API for finished-dosage manufacturing, research &amp; analytical use, and export-oriented contract manufacturing.<\/p>\n<\/section>\n<section id=\"destination-and-regions\">\n<h2><span class=\"ez-toc-section\" id=\"Destination_Source_Country_Notes_High-Interest_Regions\"><\/span>Destination \/ Source Country Notes &amp; High-Interest Regions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The primary recorded destination in the import dataset shows substantial entries labelled under India (re-entries or specific customs recording). For broader strategic planning, procurement teams should monitor supplier countries such as China, the United States, and select European chemical hubs for specialized grades.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; max-width: 100%;\" aria-label=\"Primary destination country for imports\">\n<thead>\n<tr>\n<th style=\"padding: 6px; border: 1px solid #ccc; background: #f4f4f4; font-weight: 600; word-break: break-word;\">Country (reported)<\/th>\n<th style=\"padding: 6px; border: 1px solid #ccc; background: #f4f4f4; font-weight: 600; word-break: break-word;\">Import Value (USD)<\/th>\n<th style=\"padding: 6px; border: 1px solid #ccc; background: #f4f4f4; font-weight: 600; word-break: break-word;\">Volume (KG)<\/th>\n<th style=\"padding: 6px; border: 1px solid #ccc; background: #f4f4f4; font-weight: 600; word-break: break-word;\">Avg. Price \/ KG (USD)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #ccc; word-break: break-word;\">INDIA (reported)<\/td>\n<td style=\"padding: 5px; border: 1px solid #ccc; word-break: break-word;\">7,528,257<\/td>\n<td style=\"padding: 5px; border: 1px solid #ccc; word-break: break-word;\">1,443,493<\/td>\n<td style=\"padding: 5px; border: 1px solid #ccc; word-break: break-word;\">5.21<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Top_regions_markets_searching_or_showing_rising_interest\"><\/span>Top regions \/ markets searching or showing rising interest<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Trade and search-signal monitoring indicate increased regional interest from: <strong>Cuba, Mexico, Chile, Peru, and the Philippines<\/strong>. These markets show growing demand for imported finished formulations and occasionally for API sourcing partnerships, which creates downstream demand that indirectly affects India\u2019s procurement behaviour.<\/p>\n<\/section>\n<section id=\"use-and-application\">\n<h2><span class=\"ez-toc-section\" id=\"Pharmacological_Use_Industrial_Applications\"><\/span>Pharmacological Use &amp; Industrial Applications<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paracetamol is a globally established analgesic and antipyretic. Indian formulators use imported API in a range of product types:<\/p>\n<ul>\n<li>Immediate-release tablets and caplets for OTC retail.<\/li>\n<li>Pediatric syrups and suspensions (specialized grades\/density requirements).<\/li>\n<li>Combination products (with caffeine, antihistamines, or NSAIDs).<\/li>\n<li>Injectable formulations for hospital use (requires high-purity\/sterile-grade API).<\/li>\n<li>Analytical &amp; R&amp;D supplies for stability and compatibility testing.<\/li>\n<\/ul>\n<p>Because clinical safety margins are tight for injectable products, importers often prefer tested, vendor-qualified global suppliers that meet stringent pharmacopeial standards.<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/www.apifdf.com\/blog\/wp-content\/uploads\/2025\/11\/Synthesis-of-Paracetamol-in-Lab.png\" alt=\"Paracetamol API Industry Insights \" width=\"951\" height=\"634\" \/><\/p>\n<\/section>\n<section id=\"industry-insights\">\n<h2><span class=\"ez-toc-section\" id=\"Industry_Insights_%E2%80%94_Price_Drivers_Correlations_Procurement_Signals\"><\/span>Industry Insights \u2014 Price Drivers, Correlations &amp; Procurement Signals<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Key drivers shaping import volumes and pricing:<\/p>\n<ol>\n<li><strong>Feedstock price cycles:<\/strong> the cost of intermediates such as p-aminophenol (PAP) tracks petrochemical-linked feedstock pricing.<\/li>\n<li><strong>Regulatory gating:<\/strong> purchases for regulated markets (EU, Japan) favour certified batches, which command premium pricing.<\/li>\n<li><strong>Inventory strategies:<\/strong> manufacturers use imports to manage lead-time risk and avoid production stoppages.<\/li>\n<li><strong>Contractual sourcing:<\/strong> CMOs and multinationals often require global vendor continuity, prompting imports even when local production is available.<\/li>\n<li><strong>Seasonal demand:<\/strong> cold\/flu seasons influence short-term upticks in bulk purchases for OTC lines.<\/li>\n<\/ol>\n<p class=\"note\"><strong>Search behaviour &amp; keywords:<\/strong> buyers and researchers commonly use the terms <em>\u201cacetaminophen\u201d<\/em> and <em>\u201cacetaminophen\u201d<\/em> when validating supplier qualifications, pricing, and pharmacopeial compliance. Optimizing procurement portals and product pages for both keywords improves discovery and vendor verification.<\/p>\n<\/section>\n<section id=\"future-outlook\">\n<h2><span class=\"ez-toc-section\" id=\"Future_Trade_Outlook_Strategic_Recommendations_2026%E2%80%932028\"><\/span>Future Trade Outlook &amp; Strategic Recommendations (2026\u20132028)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Outlook\"><\/span>Outlook<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>From 2026 to 2028, India\u2019s acetaminophen import patterns will likely be shaped by three converging forces:<\/p>\n<ul>\n<li><strong>Domestic capacity build-out:<\/strong> national API parks and the PLI program will increase self-sufficiency for many standard grades.<\/li>\n<li><strong>Specialized import demand:<\/strong> injectable, micronized, and analytical grades will continue to be imported where domestic supply is limited.<\/li>\n<li><strong>Regional demand growth:<\/strong> increased exports of finished dosages to emerging markets (including Cuba, Mexico, Chile, Peru, Philippines) will drive selective import requirements tied to formulation specs.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Strategic_recommendations_for_importers_policymakers\"><\/span>Strategic recommendations for importers &amp; policymakers<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ol>\n<li><strong>Diversify vendor panels:<\/strong> maintain multiple qualified suppliers across regions to mitigate single-source risk.<\/li>\n<li><strong>Invest in joint quality programs:<\/strong> co-validation with exporters to reduce batch rejection and improve lead times.<\/li>\n<li><strong>Monitor feedstock markets:<\/strong> hedging strategies on intermediates can stabilize API costs.<\/li>\n<li><strong>Prioritise traceability:<\/strong> adopt batch-level digital traceability to meet global serialization and regulatory demands.<\/li>\n<li><strong>Leverage regional opportunities:<\/strong> target growing markets (Cuba, Mexico, Chile, Peru, Philippines) for finished-dosage exports, which will influence upstream API procurement plans.<\/li>\n<\/ol>\n<p style=\"margin: 12px 0 22px;\">For additional global pharmaceutical trade references, you may review the<a href=\"https:\/\/www.who.int\/publications\" target=\"_blank\" rel=\"dofollow noopener\"><br \/>\nWHO essential medicines publications<\/a>, which offer broader context on API demand and regulatory standards.<\/p>\n<\/section>\n<section id=\"conclusion\">\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_%E2%80%94_Imports_as_a_Strategic_Supply_Lever\"><\/span>Conclusion \u2014 Imports as a Strategic Supply Lever<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>India\u2019s acetaminophen import activity through October 2025 demonstrates that even large-producing countries rely on strategic imports to meet specialised grade requirements, manage risk, and support high-quality formulation exports. While domestic manufacturing expansion will reduce dependency on routine bulk grades, imports for premium, injectable, micronized, and research-grade acetaminophen will remain a necessary and value-adding part of India\u2019s pharmaceutical supply chain.<\/p>\n<p class=\"small\">Data note: all figures and company lists in this article are sourced from consolidated trade intelligence and shipment-level records with coverage up to <strong>October 2025<\/strong>.<\/p>\n<p style=\"font-size: 0.95rem; margin: 8px 0 18px;\">For extended analysis on related import patterns, you can also review the<a href=\"https:\/\/www.apifdf.com\/blog\/indias-metformin-hcl-import-insights-2025\/\" target=\"_blank\" rel=\"dofollow noopener\"><br \/>\nIndia\u2019s Metformin HCL Import Insights 2025<\/a>published on APIFDF.<\/p>\n<\/section>\n<div style=\"text-align: center; background: #f2f7ff; padding: 15px 20px; margin: 60px 0; border: 1px solid #d9e6ff; border-radius: 12px;\">\n<h2 style=\"color: #153e90; font-size: 1.9rem; font-weight: bold; margin-bottom: 14px;\"><span class=\"ez-toc-section\" id=\"Advance_Your_Pharma_Sourcing_Strategy_with_Clear_Import_Insights\"><\/span>Advance Your Pharma Sourcing Strategy with Clear Import Insights<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"color: #333; font-size: 1.05rem; max-width: 720px; margin: 0 auto 28px; line-height: 1.7;\">Gain a sharper understanding of <strong>India\u2019s Paracetamol import ecosystem<\/strong> with concise, data-driven insights on specialty grades, pricing patterns, supplier dynamics, and procurement trends. Stay informed with <strong>credible trade intelligence<\/strong> to evaluate exporter capabilities, manage sourcing risks, and identify regions showing rising demand\u2014helping you make confident, strategy-aligned decisions in India\u2019s evolving pharmaceutical supply chain.<\/p>\n<div style=\"display: flex; justify-content: center; align-content: center; height: 57px; flex-wrap: wrap; margin-top: 3rem; margin-bottom: 1rem;\">\n<p><a style=\"margin: 8px; padding: 15px 15px; background: #153e90; color: #fff; font-size: 1rem; font-weight: 600; text-decoration: none; border-radius: 30px; box-shadow: 0 3px 10px rgba(46,125,50,0.25); transition: background 0.3s ease;\" href=\"https:\/\/apifdfanalytics.com\/request-demo\" target=\"_blank\" rel=\"noopener\">Request a Demo<\/a><\/p>\n<p><a style=\"margin: 8px; padding: 15px 15px; background: #2e7d32; color: #fff; font-size: 1rem; font-weight: 600; text-decoration: none; border-radius: 30px; box-shadow: 0 3px 10px rgba(46,125,50,0.25); transition: background 0.3s ease;\" href=\"https:\/\/www.apifdf.com\/free-trial\" target=\"_blank\" rel=\"noopener\">Start Free Trial<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Market Overview \u2014 Why India Imports Paracetamol Although India is a major global producer of Paracetamol &hellip; <a title=\"Paracetamol Imports from India: 11 Critical Market Insights\" class=\"hm-read-more\" href=\"https:\/\/www.apifdf.com\/blog\/paracetamol-imports-pharma-supply-chain\/\"><span class=\"screen-reader-text\">Paracetamol Imports from India: 11 Critical Market Insights<\/span>Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":1435,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma"],"_links":{"self":[{"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/posts\/1426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/comments?post=1426"}],"version-history":[{"count":6,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/posts\/1426\/revisions"}],"predecessor-version":[{"id":1933,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/posts\/1426\/revisions\/1933"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/media\/1435"}],"wp:attachment":[{"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/media?parent=1426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/categories?post=1426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.apifdf.com\/blog\/wp-json\/wp\/v2\/tags?post=1426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}